Literature DB >> 11039732

Studies on the interaction of REST4 with the cholinergic repressor element-1/neuron restrictive silencer element.

J H Lee1, M Shimojo, Y G Chai, L B Hersh.   

Abstract

REST4 is a neuron specific truncated form of the transcription factor REST/NRSE derived by alternative splicing. REST4 was previously shown to block the repressor activity of REST/NRSF by forming a hetero-oligomer, Shimojo et al. [Mol. Cell. Biol. 19 (1999) 6788-6795]. A series of deletion mutants have now been used to characterize REST4 in terms of its structure and DNA binding. REST4 was found to be O-glycosylated between between residues 87 and 152. Binding of REST4 to the cholinergic RE-1/NRSE was approximately 1/10 to 1/20 as strong as full length REST/NRSF. DNA binding was enhanced by deletion of the first 86 residues and was found to require all four of the C-terminal zinc fingers as well as a twelve amino acid sequence preceding the first of these zinc fingers. REST4 can form homo-oligomers, however only the monomer was found to bind to DNA. REST4 binds to the 3' sequence of the cholinergic NRSE suggesting an anti-parallel orientation of the protein to the DNA.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11039732     DOI: 10.1016/s0169-328x(00)00129-7

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  12 in total

1.  Transformation by E1A oncoprotein involves ubiquitin-mediated proteolysis of the neuronal and tumor repressor REST in the nucleus.

Authors:  Hancheng Guan; Robert P Ricciardi
Journal:  J Virol       Date:  2012-03-14       Impact factor: 5.103

Review 2.  REST and CoREST are transcriptional and epigenetic regulators of seminal neural fate decisions.

Authors:  Irfan A Qureshi; Solen Gokhan; Mark F Mehler
Journal:  Cell Cycle       Date:  2010-11-15       Impact factor: 4.534

3.  Molecular profiling stratifies diverse phenotypes of treatment-refractory metastatic castration-resistant prostate cancer.

Authors:  Mark P Labrecque; Ilsa M Coleman; Lisha G Brown; Lawrence D True; Lori Kollath; Bryce Lakely; Holly M Nguyen; Yu C Yang; Rui M Gil da Costa; Arja Kaipainen; Roger Coleman; Celestia S Higano; Evan Y Yu; Heather H Cheng; Elahe A Mostaghel; Bruce Montgomery; Michael T Schweizer; Andrew C Hsieh; Daniel W Lin; Eva Corey; Peter S Nelson; Colm Morrissey
Journal:  J Clin Invest       Date:  2019-07-30       Impact factor: 14.808

4.  Expression patterns of mouse repressor element-1 silencing transcription factor 4 (REST4) and its possible function in neuroblastoma.

Authors:  J H Lee; Y G Chai; L B Hersh
Journal:  J Mol Neurosci       Date:  2000-12       Impact factor: 3.444

5.  Profiling RE1/REST-mediated histone modifications in the human genome.

Authors:  Deyou Zheng; Keji Zhao; Mark F Mehler
Journal:  Genome Biol       Date:  2009-01-27       Impact factor: 13.583

6.  CFP1 interacts with DNMT1 independently of association with the Setd1 Histone H3K4 methyltransferase complexes.

Authors:  Jill Sergesketter Butler; Jeong-Heon Lee; David G Skalnik
Journal:  DNA Cell Biol       Date:  2008-10       Impact factor: 3.311

Review 7.  Regulation of non-coding RNA networks in the nervous system--what's the REST of the story?

Authors:  Irfan A Qureshi; Mark F Mehler
Journal:  Neurosci Lett       Date:  2009-08-11       Impact factor: 3.046

Review 8.  Selective repression of gene expression in neuropathic pain by the neuron-restrictive silencing factor/repressor element-1 silencing transcription (NRSF/REST).

Authors:  Dianna E Willis; Meng Wang; Elizabeth Brown; Lilah Fones; John W Cave
Journal:  Neurosci Lett       Date:  2015-12-08       Impact factor: 3.046

9.  Non-Coding RNAs in Neural Networks, REST-Assured.

Authors:  Michael Rossbach
Journal:  Front Genet       Date:  2011-02-28       Impact factor: 4.599

10.  The deubiquitylase USP15 stabilizes newly synthesized REST and rescues its expression at mitotic exit.

Authors:  Monica Faronato; Vruti Patel; Sarah Darling; Laura Dearden; Michael J Clague; Sylvie Urbé; Judy M Coulson
Journal:  Cell Cycle       Date:  2013-05-20       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.